Your browser doesn't support javascript.
loading
Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
Harrison, Ross F; Fu, Shuangshuang; Sun, Charlotte C; Zhao, Hui; Lu, Karen H; Giordano, Sharon H; Meyer, Larissa A.
Affiliation
  • Harrison RF; Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Fu S; Cancer Prevention and Population Sciences Division, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sun CC; Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Zhao H; Cancer Prevention and Population Sciences Division, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lu KH; Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Giordano SH; Cancer Prevention and Population Sciences Division, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Meyer LA; Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX; Cancer Prevention and Population Sciences Division, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, T
Am J Obstet Gynecol ; 225(1): 68.e1-68.e11, 2021 07.
Article in En | MEDLINE | ID: mdl-33549538

Full text: 1 Main subject: Ovarian Neoplasms / Cost Sharing / Poly(ADP-ribose) Polymerase Inhibitors Type of study: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Am J Obstet Gynecol Year: 2021 Type: Article

Full text: 1 Main subject: Ovarian Neoplasms / Cost Sharing / Poly(ADP-ribose) Polymerase Inhibitors Type of study: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Am J Obstet Gynecol Year: 2021 Type: Article